Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 3/20 | 0.55 |
| ▸ | NPBWR1 | P48145 | 14/20 | 0.53 |
| ▸ | KISS1R | Q969F8 | 2/20 | 0.53 |
| ▸ | CCKAR | P32238 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29519607 | 0.87 | NPY1R (0.56) | CCKBRKISS1R | |
| SCHEMBL30366588 | 0.80 | KISS1R (0.60) | CCKBRKISS1RCCKAR | |
| SCHEMBL29519296 | 0.80 | KISS1R (0.60) | CCKBRKISS1RCCKAR | |
| SCHEMBL30494060 | 0.80 | KISS1R (0.60) | CCKBRKISS1R | |
| SCHEMBL29849030 | 0.79 | NPY1R (0.57) | CCKBRKISS1R | |
| SCHEMBL30618455 | 0.79 | NPY1R (0.57) | CCKBRKISS1R | |
| SCHEMBL31055392 | 0.79 | CCKBR (0.48) | CCKBRCCKAR | |
| SCHEMBL31504099 | 0.78 | PRMT1 (0.57) | CCKBRNPBWR1KISS1RCCKAR | |
| SCHEMBL29388966 | 0.78 | PRMT1 (0.57) | CCKBRNPBWR1KISS1RCCKAR | |
| SCHEMBL29620375 | 0.77 | CCKAR (0.55) | CCKBRNPBWR1CCKAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | LONGEVITY BIOTECH, INC. | 2024-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240374689-A1 | HIGHLY ACTIVE POLYPEPTIDES AND METHODS OF MAKING AND USING THE SAME | SCTR, GIPR, APLNR | CCKBR 257/4885NPBWR1 34/4885KISS1R 1232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.